Oligonucleotide Synthesis Market – Top Participant to Focus on Regional ExpansioPosted by sachi kaushik on March 19th, 2021 Over the years, application of oligonucleotides has been widespread in the healthcare industry. They are generally used to determine DNA sequences in gene reconstruction and site-directed mutagenesis. They are also used to inhibit gene expression in in-vitro studies for diagnostic purposes. Such a vast applicability of oligonucleotides have prompted an array of developments in synthetic chemistry. To remain ‘ahead’ of your competitors, request for a sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4853 Integrated DNA Technologies, for instance, is a company extensively engaged in the development of oligonucleotides up to 200 base length, suitable for usage in manufacturing mini-genes. Based on these trends, the global oligonucleotide synthesis market is poised to propel towards positive growth, registering a staggering CAGR of 11.3% during the forecast period (2020-2025). Key Takeaways of the Global Oligonucleotide Synthesis Market Study
”The global oligonucleotide synthesis market exhibits an upward trend. As the nature of health problems becomes complicated with each passing day, demand for more robust and state-of-the-art treatment facilities is increasing. Considering the existing scenario, key market players are concentrating on introducing pathways in synthetic chemistry,” observes the Fact.MR analyst. Impact of COVID-19 on the Oligonucleotide Synthesis Market The coronavirus pandemic has ushered in an unprecedented time in human history. Preceded by the Spanish Flu in the 20th century, the coronavirus pandemic is the second-most fatal pandemic ever to have plagued humanity. As the number of infections continues to proliferate, healthcare providers are putting their best foot forward to contain its spread. The global oligonucleotide synthesis market has received immense impetus from the pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19. Pioneering research and development is being undertaken by bioSynthesis, a leading vendor. It has doled out ready-to-use cocktail mixes such as the SARS-CoV-2 N1 Oligo Mix, the SARS-CoV-2 N2 Oligo Mix and the Human RNase P (RP) Oligo Mix respectively. Such breakthroughs are generating a level of optimism amongst healthcare providers and stimulating them to keep the anti-coronavirus battle raging. Product Development – A Key Growth Stimulant for Market Players The global oligonucleotide market consists of the following market players: Thermo Fisher Scientific Corporation, Integrated DNA Technologies, Inc., Sigma-Aldrich Corporation (a part of Merck KGaA), GE Healthcare, Kaneka Eurogentec S.A., TriLink Biotechnologies, LLC (Maravai Life Sciences), BioAutomation and ATDBio Ltd., to name a few. Integrated DNA Technologies is the leader in the global oligonucleotide synthesis market. It supplies custom oligonucleotides for academic and pharmaceutical research as well as pharmaceutical drug development. It has a strong focus on delivering excellent customer service. Its products include the Ultramer DNA Oligos and Primer Mix DNA Plate Oligos. BioAutomation, another player, provides automation solutions to research institutes to enable them to conduct studies surrounding advancements in the biotechnology industry. Products offered by BioAutomation include the MerMade 48X oligonucleotide synthesizer, the MerMade 96E oligonucleotide synthesizer and the MerMade 192E/R/X oligonucleotide synthesizers. Looking for more information? The research study on the global oligonucleotide synthesis market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the market over 2020-2025. It includes a detailed assessment of key parameters that are anticipated to exert influence during the predefined period. Market statistics have been presented on the basis of product (Reagents & Consumables, Equipment and Synthesized Oligonucleotides), application (Research, Therapeutics and Diagnostics) and end user (Biotechnology & Pharmaceutical Companies, Research Institutes and Diagnostic Laboratories) across five major regions. About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: US Sales Office: Corporate Headquarter: Like it? Share it!More by this author |